Efficacy of Botulinum Toxin Type A for Treating Chronic Low Back Pain

Abstract

Background: Low back pain is a major cause of disability and can result in substantial morbidity Objectives: The aim of this study was to investigate the efficacy of botulinum toxin type A Patients and Methods: This was a single-blind, randomized clinical trial study. Fifty patients with CLBP Results: After 4 weeks, 76% of patients in the BoNT-A group reported pain relief compared to 20% Conclusions: BoNT-A improves CLBP with a low incidence of side effects and can be used as a